What guidance did Crescent Capital's management provide for the next earnings period?

What does Crescent Capital do and what are its main business segments?

What were the key takeaways from Crescent Capital's earnings call?

What is Crescent Capital's gross profit margin?

What were the key takeaways from Crescent Capital’s earnings call?

Did Crescent Capital beat or miss consensus estimates last quarter?

What is Crescent Capital's latest dividend and current dividend yield?

What is the market's earnings forecast for Crescent Capital next quarter?

- **Dividend Sustainability**: Q4 NII of $0.45 per share (107% dividend coverage) despite rate headwinds, with spillover income of $1.16 per share providing buffer.
- **Portfolio Resilience**: 91% first lien loans, 99% sponsor-backed, and 71% with covenants. Q4 nonaccruals at 4.1% of cost, but January actions reduced pro forma to 1.4%.
- **Balance Sheet Strength**: Debt-to-equity 1.25x, $242M undrawn capacity, and 2028+ maturity extension via $185M notes.
- **Strategic Review**: Board evaluating dividend policy and fee structure for long-term alignment, with updates in Q1 2026.
- **Market Outlook**: Spreads stabilizing at 475-500bps, cautious but improving LBO activity, and software portfolio generating strong cash flows.

**【CEO Summary Section】**
- Q4 2025 net investment income (NII) of $0.45 per share, down from $0.46 in Q3, but still covering the $0.42 quarterly dividend (107% coverage). 
- NAV per share declined to $19.10 (from $19.28 in Q3) due to unrealized losses, but management emphasizes long-term stability with a 30-year track record of conservative underwriting.
- 2025 total origination volume of $6.5B ($1.7B in Q4), with 50% of transactions coming from portfolio add-ons.
- Spillover income of $1.16 per share provides significant cushion against rate headwinds.
- Board reviewing dividend policy and earnings sustainability, with updates expected in Q1 2026 earnings call.

**【CFO Financial Commentary】**
- Q4 2025 balance sheet: $1.6B investment portfolio at fair value, $706M total net assets, and $19.10 NAV per share.
- Debt-to-equity ratio of 1.25x (1.2x net of cash), within target range of 1.1x-1.3x.
- $185M senior unsecured notes issued in Q4, extending maturity profile to 2028+.
- Weighted average interest rate on borrowings decreased to 5.83% (from 5.99% in Q3) due to lower base rates.
- $242M undrawn credit capacity and $30M cash provide liquidity for selective deployment.

**【Q&A Key Highlights】**
- **Dividend Policy Review**: Management evaluating fee structure and base dividend level relative to forward earnings, with focus on long-term earnings durability. Current over-earning (107%) provides stability but Board considering adjustments for lower rate environment.
- **Nonaccrual Management**: Q4 nonaccruals at 4.1% of cost (2% of fair value), but January restructuring and sale reduced pro forma nonaccruals to 1.4% of cost. Idiosyncratic issues vs. broader portfolio weakness.
- **Market Activity**: Q4 and early 2026 transaction volumes up, with spreads stabilizing at 475-500bps over SOFR for new first lien loans. LBO activity cautious but improving.
- **Buyback Program**: Continuing share repurchases while maintaining portfolio deployment, balancing ROE from new investments vs. NAV discount arbitrage.
- **Software & Services Portfolio**: 20% of portfolio, with strong cash flow generation and mission-critical value propositions. No ARR loans; focus on first lien, sponsor-backed companies with 40% LTV.

Crescent Capital BDC, Inc.(CCAP)-20260226-2025 Q4 Earnings call transcript

- **Stable NII & Dividend Coverage**: $0.46 NII with 110% dividend coverage, $0.42 Q4 dividend declared.
- **Portfolio Resilience**: 90% first lien loans, 97% floating rate, 1.6% nonaccruals despite tariff impact.
- **Debt Optimization**: Extended maturity profile with $185M senior notes issuance.
- **Key Risks**: Tariff-related losses ($0.15 per share), 13% watch list exposure.
- **Growth Levers**: $6B+ origination pipeline, spillover income cushion, noninterest fee potential.

**【CEO Summary Section】**
- Reported net investment income (NII) of $0.46 per share, maintaining 110% dividend coverage for the quarter.
- NAV declined to $19.28 per share due to unrealized losses from tariffs impacting two portfolio companies.
- Emphasized resilience in the U.S. economy and focus on core/lower middle market with 90% of portfolio in first lien loans.
- Declared Q4 dividend of $0.42 per share, 9% annualized yield on NAV.

**【Portfolio Overview】**
- $1.6 billion diversified portfolio across 187 companies, avg. 0.6% per investment.
- 99% of debt backed by private equity sponsors with 40% LTV at origination.
- Weighted average yield of 10.4% (stable Q/Q), 97% floating rate with 77bp floor.
- Nonaccruals improved to 1.6% (from 2.4%), watch list at 13% of portfolio.

**【Financial Highlights】**
- Q3 net income $0.19 per share vs. $0.41 prior quarter, driven by realized/unrealized losses.
- Debt-to-equity ratio 1.20x (target 1.1-1.3x), $240M undrawn capacity.
- Issued $185M senior notes to extend maturity profile, weighted avg rate 5.99%.
- Spillover income of $1.10 per share provides cushion against rate headwinds.

**【Q&A Highlights】**
- **Dividend Sustainability**: CEO confident in maintaining dividend through portfolio growth, noninterest income, and spillover usage.
- **Tariff Impact**: Two companies (export-dependent) saw weakened outlooks, but 87% of portfolio performing at/above expectations.
- **Market Competition**: Maintaining spreads through add-on investments (33-50% of origination), no compromise on covenant quality.
- **Family Dollar Investment**: Asset-based lending focused on hard collateral, not consumer demand.
- **CECO Valuation**: Nonaccrual reflects near-term uncertainty in 3PL sector, conservative outlook.


Crescent Capital BDC, Inc. (CCAP) Q3 2025 Earnings Call Transcript

- **Earnings Resilience**: 110% dividend coverage and stable NII of $0.46 per share highlight financial discipline.
- **NAV Stability**: 0.4% decline driven by special dividend, maintaining long-term NAV growth vs. -10.5% peer decline since 2020.
- **Credit Quality**: 86% of portfolio performing as expected, with watch list at 14% reflecting proactive risk management.
- **Market Adaptation**: 50% of Q2 investments in add-ons, leveraging incumbency to navigate regulatory uncertainty.
- **Share Buyback**: $20M program to capitalize on discount, balancing with disciplined capital allocation.

**【CEO Summary Section】**
- **Stable Earnings Growth**: Reported NII of $0.46 per share (excluding $0.02 one-time charge), with 110% dividend coverage, marking 38 consecutive quarters of dividend payment.
- **NAV Stability**: NAV per share decreased 0.4% to $19.55, driven by $0.05 special dividend, maintaining NAV within a tight band since listing in 2020.
- **Market Positioning**: Amid regulatory uncertainty, 50% of Q2 investments were add-ons to existing portfolio companies, leveraging incumbency and sponsor relationships.
- **Long-Term Track Record**: Since 2020, NAV increased 0.6% vs. -10.5% for peers, with total economic return of 49%.
- **Share Repurchase Program**: $20 million authorized to repurchase shares at discount, balancing with investment pipeline.

**【CFO Financial Commentary】**
- **Balance Sheet Health**: Debt-to-equity ratio of 1.23x (target 1.1x-1.3x), with 74% of debt maturing post-2028 and weighted average interest rate of 6.09%.
- **Liquidity Management**: Resized SPV facility to $400 million (from $500M), reducing rate by 50bps to 195bps, lowering interest expense.
- **Dividend Policy**: Q3 regular dividend of $0.42 declared, with final $0.05 special dividend in September; no supplemental dividend due to earnings cap.

**【Q&A Key Highlights】**
- **Credit Quality**: Watch list at 14% (vs. 12% prior quarter), with 86% of portfolio rated 1-2 (performing as expected). Nonaccruals at 2.4%, below peer average.
- **Tariff Impact**: <5% of portfolio directly affected; companies mitigating via pricing power and supply chain diversification.
- **Portfolio Rotation**: Focused on rotating acquired assets (e.g., First Eagle, Alcentra) into higher-yielding originated deals, maintaining 91% first lien concentration.
- **Second Lien Strategy**: Minimal allocation (2% of portfolio) due to tight spreads; prioritize first lien for risk-adjusted returns.
- **Energy Costs**: Service-oriented portfolio limits exposure to fuel price volatility, with wage costs as primary expense driver.

Crescent Capital BDC, Inc. (CCAP) Q2 2025 Earnings Call Transcript

- **Q1 NII decline**: $0.45 vs. $0.55 prior quarter due to rate lag, nonrecurring income runoff, and Logan JV dividend drop.
- **Nonaccruals contained**: 4 new positions (<1.2% of portfolio) from isolated credit events, no material impact on portfolio stability.
- **Portfolio resilience**: 91% first lien, 39% LTV, 2x interest coverage, and <4% tariff exposure limit risk.
- **Leverage optimized**: SPV facility rightsized to 6.17% WACC, 76% debt maturing post-2027, within 1.1-1.3x target range.
- **Dividend sustainability**: 37 quarters of earning base dividend, focus on long-term stability over yield.

**【CEO Summary Section】**
- Q1 2025 net investment income (NII) was $16.6 million ($0.45 per share), down 19% from Q4 2024 due to lower base rates, nonrecurring income runoff, and reduced Logan JV dividends. 
- Nonaccrual loans rose to 3.5% of debt investments at cost, driven by 4 new first lien positions (<1.2% of portfolio) from one-off credit events. 
- Near-term NII baseline of $0.45-$0.47 per quarter assumes no further rate changes or nonaccruals. 
- Portfolio remains highly diversified (191 companies, <1% avg position size) with 91% first lien exposure and 39% LTV. 
- Dividend policy prioritizes long-term stability over yield, with 37 consecutive quarters of earning base dividend.

**【CFO Financial Commentary】**
- Q1 GAAP EPS was $0.11 vs. $0.34 in Q4, driven by $0.34 per share net unrealized losses. 
- 4 key NII drivers: 
  1. Lower base rates (-$0.04) 
  2. Nonrecurring PIK income runoff (-$0.03)
  3. Logan JV dividend decline (-$0.03)
  4. New nonaccruals (-$0.02)
- SPV asset-based facility was rightsized to $400M with 50bp spread reduction, lowering weighted average interest rate to 6.17%. 
- Debt-to-equity ratio at 1.25x (target 1.1-1.3x), with 76% of debt maturing post-2027.
- Q2 2025 regular dividend of $0.42 declared, plus $0.05 special dividend for tax efficiency.

**【Q&A Highlights】**
- **Nonaccrual Management**: Crescent takes long-term view, preserves capital through restructuring, sponsor support, or sale. 3 new nonaccruals were watch list names with one-off issues. 
- **Market Risks**: Portfolio has <4% direct tariff exposure, focused on low-materials service businesses. 90-day tariff pause caused PE sponsors to pause new platform activity. 
- **Logan JV Outlook**: CLO dividend will decline as deleveraging continues, with full wind-down expected in 24 months. Recent reinvestments at post-Liberation Day prices may provide near-term lift. 
- **Buyback Consideration**: Board evaluates share price vs. long-term portfolio stability, but prioritizes high-quality asset deployment over short-term NAV boosts.

Crescent Capital BDC (CCAP)-15 May 25-2025 Q1 Earnings call transcript

- **NII and NAV Performance**: Q4 NII of $0.55 per share (11% annualized) with 131% dividend coverage, despite 0.3% NAV decline.
- **Portfolio Strength**: 90% first lien loans, 99% sponsor-backed, and nonaccruals at 0.9% (industry low).
- **Leverage and Liquidity**: Debt-to-equity at 1.19x, with $338M undrawn capacity to support growth.
- **Key Risks**: Watch list expansion in logistics, packaging, and med tech; 12% portfolio exposure to tariffs.
- **Dividend Action**: Q1 2025 base dividend of $0.42 plus $0.03-$0.05 special dividends per quarter.

**【CEO Summary Section】**
- Reported NII of $0.55 per share for Q4 2024, down from $0.64 in Q3, due to lower investment portfolio yield and reduced nonrecurring income.
- NAV per share decreased to $19.98, down 0.3% year-over-year, driven by unrealized marks.
- Portfolio remains highly diversified across 185 companies, with 90% in first lien loans and 99% backed by private equity sponsors.
- Nonaccruals at 0.9% of debt investments, below industry average, reflecting strong credit performance.
- Dividend coverage at 131%, with Q1 2025 base dividend of $0.42 declared.

**【CFO Financial Commentary】**
- GAAP net income of $0.27 per share, with NII of $0.55 offset by unrealized losses.
- Weighted average yield on income-producing securities at 10.9%, down due to base rate cuts.
- Debt-to-equity ratio at 1.19x, within target range of 1.1x-1.3x, with $338 million undrawn capacity.
- Capital structure optimized with 25% of debt maturing in 2026, down from 58% in Q3.
- Special dividends of $0.03-$0.05 per share announced for Q1-Q3 2025.

**【Q&A Key Themes】**
- **Risk Watch List**: 7 new names added to watch list, primarily in third-party logistics, packaging, and early-stage med tech/biotech sectors.
- **Tariff Exposure**: ~12% of portfolio exposed to foreign-sourced materials; <5% tied to government contracts.
- **Market Repricing**: 20% of back book may face repricing risk if LBO volumes remain sluggish; spreads in lower middle market stable at ~500bps.
- **Nonaccruals**: 3 of 4 new nonaccruals in Q4 were legacy acquisitions, reflecting prudent risk management.


Actual	0.43	0.47	0.41	0.39	0.45	0.42	0.39	0.5	0.52	0.52	0.54	0.56	0.59	0.61	0.63	0.59	0.64	0.55	0.45	0.46	0.46	0.45
Forecast	0.48	0.46	0.47	0.45	0.415	0.4133	0.41	0.4138	0.4333	0.4367	0.4575	0.5471	0.5577	0.5701	0.5781	0.5807	0.5781	0.5632	0.5276	0.4697	0.4654	0.4353
Surprise	-10.42%	+2.17%	-12.77%	-13.33%	+8.43%	+1.62%	-4.88%	+20.83%	+20.01%	+19.07%	+18.03%	+2.36%	+5.79%	+7.00%	+8.98%	+1.60%	+10.71%	-2.34%	-14.71%	-2.07%	-1.16%	+3.38%

CCAP

CCAP fundamentals

CCAP Q4 2025 Earnings

Earnings Call

You can ask Aime

CCAP

CCAP fundamentals

CCAP Q4 2025 Earnings

Earnings Call

CCAP Earnings Call Summary for Q4/202512:00 PM on Feb 26, 2026

CCAP Earnings Call Summary for Q3/202512:00 PM on Nov 13, 2025

CCAP Earnings Call Summary for Q2/202512:00 PM on Aug 14, 2025

CCAP Earnings Call Summary for Q1/202512:00 PM on May 15, 2025

CCAP Earnings Call Summary for Q4/202412:00 PM on Feb 20, 2025

You can ask Aime